PCSK9
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assessed by CT Angiography (NCT06863545) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2025-04-22 |
| Proprotein Convertase Subtilisin Kexin 9 in Rheumatoid Arthritis (NCT05191342) | First Affiliated Hospital of Harbin Medical University | 2021-11-01 |
| Application of PCSK9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia (NCT04759534) | Shenzhen People's Hospital | 2020-09-10 |
| Effect of Fish Oil Enriched In Omega-11 Fatty Acid On Lipoprotein Metabolism In Adults (NCT03043365) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-06-15 |
| COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients (NCT03139630) | Franck Boccara | 2016-03-01 |
| Comparison of EPA and DHA-Rich Fish Oils on Lipoprotein Metabolism In Adults (NCT02514070) | National Heart, Lung, and Blood Institute (NHLBI) | 2015-10-30 |
Track PCSK9 automatically
Every clearance here is in the API, with alerts when new ones post.